教員紹介

Aurelia Vessiere 准教授

専門・研究テーマ・キーワード
新興感染症、疫学、臨床研究、診断学、アウトブレイク対策、資源が限られた状況下
担当課程
博士前期課程専任教員博士後期課程専任教員

取得学位・資格

PhD Communicable Diseases and Tropical Pathologies (France), PgDip Epidemiology (UK), MSc Biological Anthropology (France), MSc Communicable Diseases and Tropical Pathologies (France)

連絡先

aurelia.vessiere@nagasaki-u.ac.jp; aurelia.vessiere@lshtm.ac.uk

他所属

  • Department of Infectious Disease Epidemiology and International Health, London School of Tropical Medicine and Hygiene, UK
  • School of Tropical Medicine and Global Health, Nagasaki University, Japan

経歴

Trained in tropical infectious diseases and virology, I has extensive experience in clinical research and epidemiology of emerging infectious diseases, as well as major endemic diseases like HIV, malaria and TB. I held positions at various public and private institutions, including FIND (Switzerland); University of Bordeaux (France); University of Oxford (UK); University of Tulane (USA); French National Agency for AIDS Research; and Pasteur Institute in Cameroon. I also worked as an independent consultant in virology, and as an expert to the European Commission and the WHO.

教育活動

  • Epidemiology
  • Clinical Trials

研究活動

My research interest has been on tropical and outbreak-prone diseases. I mainly focused on the surveillance and characterization of emerging variants, as well as improving diagnosis and patient management, with a « research-to-policy » vision.
I have been very involved in capacity strengthening of resource-limited health settings, especially Sub-Saharan Africa, while being strongly attached to building equitable research partnerships. Every projects I have been involved in were designed for a direct benefit to patients and populations, with the ultimate goal of supporting strong and resilient health systems, especially at the primary health care level.

現在の主な研究活動地域

  • Japan
  • The Philippines
  • West Africa

最近の5つの出版物

  1. Chi H, Etafo J, Fonkeng F, Gbenga-Ayeni O, Ronke I, Abejegah C, Owhin S, Bausch DG, Vessière A, Agogo E, Emperador DM, Adedosu NA. Evaluation of the Diagnostic Accuracy of the ReLASVTM Pan-Lassa Antigen Rapid Test for Lassa Fever in Nigeria. PLOS Global Public Health 2024 [submitted].

  2. Hoppe A, Vessiere A, and Bausch DG. Leveraging Covid-19 Diagnostics to Confront both Epidemic and Endemic Diseases. In: Evaluating Covid-19. Editor Charles Pasternak. World Scientific Publishing, October 2023. https://doi.org/10.1142/13039

  3. Escadafal C, Baldan R, De Vos M, Ruiz RJ, Emperador DM, Murahwa A, Mace A, Bausch DG, Vessière A, Sacks JA. Evaluating Diagnostic Tests During Outbreaks: Challenges and Lessons Learned from COVID-19. BMJ Glob Health. 2023 Jul;8(7):e012506.

  4. Marcy O, Wobudeya E, Font H, Vessière A, et al.; TB-Speed Pneumonia Study Group. Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial. Lancet Infect Dis. 2023 Mar;23(3):341-51.

  5. Vessière A, Font H, Gabillard D, et al. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries: Study protocol for a stepped wedge cluster-randomized trial (TB-Speed Pneumonia). BMC Pediatr 2021 Mar 20;21(1):136.

PAGE TOP
HSR2024